BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1645 related articles for article (PubMed ID: 31520783)

  • 1. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China.
    Fan X; Xiao M; Zhang D; Huang JJ; Wang H; Hou X; Zhang L; Kong F; Chen SC; Tong ZH; Xu YC
    Clin Microbiol Infect; 2019 Jul; 25(7):885-891. PubMed ID: 30472420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of CDR1 and MDR1 Gene Expression and ERG11 Substitutions in Clinical Candida tropicalis Isolates from Alexandria, Egypt.
    El-Kholy MA; Helaly GF; El Ghazzawi EF; El-Sawaf G; Shawky SM
    Braz J Microbiol; 2023 Dec; 54(4):2609-2615. PubMed ID: 37606863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
    Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APX001A
    Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and Antifungal Susceptibility of
    Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
    Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India.
    Singh A; Singh PK; de Groot T; Kumar A; Mathur P; Tarai B; Sachdeva N; Upadhyaya G; Sarma S; Meis JF; Chowdhary A
    J Antimicrob Chemother; 2019 May; 74(5):1260-1268. PubMed ID: 30753525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence and circulation of azole-resistant
    Ceballos-Garzon A; Peñuela A; Valderrama-Beltrán S; Vargas-Casanova Y; Ariza B; Parra-Giraldo CM
    Front Cell Infect Microbiol; 2023; 13():1136217. PubMed ID: 37026059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?
    Xisto MI; Caramalho RD; Rocha DA; Ferreira-Pereira A; Sartori B; Barreto-Bergter E; Junqueira ML; Lass-Flörl C; Lackner M
    J Antimicrob Chemother; 2017 Apr; 72(4):988-992. PubMed ID: 28065893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain.
    Alcoceba E; Gómez A; Lara-Esbrí P; Oliver A; Beltrán AF; Ayestarán I; Muñoz P; Escribano P; Guinea J
    Clin Microbiol Infect; 2022 Aug; 28(8):1113-1119. PubMed ID: 35439634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years.
    Demirci-Duarte S; Arikan-Akdagli S; Gülmez D
    Mycoses; 2021 Aug; 64(8):823-830. PubMed ID: 33934400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait.
    Asadzadeh M; Ahmad S; Al-Sweih N; Khan Z
    Microb Drug Resist; 2017 Dec; 23(8):966-972. PubMed ID: 28353392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation.
    Corzo-Leon DE; Peacock M; Rodriguez-Zulueta P; Salazar-Tamayo GJ; MacCallum DM
    Med Mycol; 2021 Jul; 59(7):664-671. PubMed ID: 33305313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
    Jensen RH; Astvad KM; Silva LV; Sanglard D; Jørgensen R; Nielsen KF; Mathiasen EG; Doroudian G; Perlin DS; Arendrup MC
    J Antimicrob Chemother; 2015 Sep; 70(9):2551-5. PubMed ID: 26017038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.